Pet Biotics Market - Global Forecast To 2030
商品番号 : SMB-91624
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年11月 |
| ページ数 | 320 |
| 図表数 | 395 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
ペット用バイオティクス市場 – タイプ（プロバイオティクス、プレバイオティクス、ポストバイオティクス）、用途（ドライ、ウェット、サプリメント、スナック＆トリーツ）、ペット（犬、猫、その他のペット）、形状、機能、製造技術、地域別 – 2030年までの世界予測
ペット用バイオティクス市場は、2025年に8億7,810万米ドルに達すると推定され、2030年には12億3,250万米ドルに達し、年平均成長率（CAGR）7.0%で成長すると予測されています。世界のペットバイオティクス市場は、ペットの人間化の進展に牽引され、著しい成長を遂げています。飼い主は人間の栄養に使用されているものと同様のマイクロバイオームをサポートするソリューションを求めており、高度な腸内環境改善成分の需要が高まっています。さらに、免疫力、ストレス軽減、消化、健康全般など、予防医療への関心が高まっており、プロバイオティクス、プレバイオティクス、ポストバイオティクスなどの機能性バイオティクスが、ペットフード、サプリメント、おやつ、スナックに使用されるケースが増えています。さらに、プレミアム化のトレンドや、天然由来、クリーンラベル、科学的に裏付けられた処方への移行により、高品質で臨床的に検証されたバイオティクス株に大きなチャンスが生まれています。さらに、個別化され状態に特化した栄養の急増により、敏感性、加齢に伴う問題、品種特有のニーズに対応するターゲットを絞ったバイオティクスへの道が開かれています。
しかし、高品質菌株のサプライチェーンの複雑さ、地域間の規制の不一致、そして消費者の信頼を築くための強力な科学的裏付けの必要性は、ペットバイオティクス市場において課題となることが予想されます。さらに、様々なペットフードマトリックスにおけるバイオティクスの安定性と生存性を確保することも、依然として技術的な課題となっています。
調査対象範囲
本調査レポートでは、ペット用バイオティクス市場を、種類（プロバイオティクス、プレバイオティクス、ポストバイオティクス）、用途（ドライフード、ウェットフード、サプリメント、スナック＆トリーツ）、ペット（犬、猫、その他のペット）、機能（消化器系／腸内環境の健康、免疫調節、代謝・体重管理、口腔・歯の健康、その他の機能）、製造技術（定性的）（発酵、遠心分離・ろ過、乾燥・安定化、カプセル化・保護、不活化・細胞破壊、配合・混合、品質管理・保管）、地域（北米、欧州、アジア太平洋、南米、その他の地域）に分類しています。
本レポートは、ペット用バイオティクス業界の成長に影響を与える主要な要因（促進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーを徹底的に分析し、各社の事業、サービス、主要戦略、契約、パートナーシップ、合意、製品発売、合併・買収、そしてペットバイオティクス市場に関連する最近の動向に関する洞察を提供しています。本レポートは、ペットバイオティクス市場エコシステムにおける新興スタートアップ企業の競争力分析を提供しています。さらに、技術分析、エコシステムと市場のマッピング、特許と規制の状況など、業界固有のトレンドについても調査しています。
このレポートを購入する理由
本レポートは、市場リーダー企業および新規参入企業に対し、ペット用バイオティクス全体とそのサブセグメントの収益数値に関する近似値に関する情報を提供します。これにより、関係者は競争環境を理解し、自社のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めることができます。また、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供することで、市場の動向を把握するのに役立ちます。
本レポートでは、以下の点について洞察を提供しています。
ペットバイオティクス市場の成長に影響を与える主要な推進要因（ペットの人間化の高まりと予防医療への関心）、制約要因（微生物株の熱と湿気に対する感受性）、機会（腸内環境と機能性を重視したペットフードの需要増加）、課題（生きた微生物のサプライチェーンの複雑性）の分析
- 製品開発／イノベーション：ペット用バイオティクス市場における研究開発活動と新製品発売に関する詳細な洞察
- 市場開発：収益性の高い市場に関する包括的な情報、様々な地域におけるペットバイオティクスの分析
- 市場多様化：ペット用バイオティクス市場における新製品ソース、未開拓地域、最近の動向、投資に関する網羅的な情報
- 競合評価：ADM（米国）、Alltech（米国）、Kerry Group plc（アイルランド）、International Flavors & Fragrances Inc.（米国）、dsm-firmenich（オランダ）、Cargill, Incorporated（米国）、Probi（スウェーデン）、Kemin Industries, Inc.（米国）、BENEO GmbH（ドイツ）、Ingredion（米国）、Lallemand Inc.（カナダ）、Sacco System（イタリア）、Phileo by Lesaffreなどの主要企業の市場シェア、成長戦略、製品ラインナップ、ブランド／製品比較、製品フットプリントに関する詳細な評価(フランス)、Sanzyme Biologics (インド)、Orffa (オランダ)、BIO-CAT (米国)、およびペットバイオティクス市場のその他の企業。
Report Description
The pet biotics market is estimated to be worth USD 878.1 million in 2025 and is projected to reach USD 1,232.5 million by 2030, at a CAGR of 7.0%. The global pet biotics market is experiencing significant growth, driven by the rising humanization of pets, which is increasing demand for advanced gut-health ingredients as owners seek microbiome-supporting solutions similar to those used in human nutrition. Additionally, there is a growing focus on preventive health, including immunity, stress reduction, digestion, and overall health performance, which is accelerating the use of functional biotics such as probiotics, prebiotics, and postbiotics, in pet food, supplements, treats & snacks. Furthermore, premiumization trends and the shift toward natural, clean-label, and scientifically backed formulations create strong opportunities for high-quality, clinically validated biotic strains. Additionally, the surge in individualized and condition-specific nutrition opens the door for targeted biotics addressing sensitivities, age-related issues, and breed-specific needs.
However, supply chain complexity for high-quality strains, regulatory inconsistencies across regions, and the need for strong scientific substantiation to build consumer trust are expected to pose challenges in the pet biotics market. Furthermore, ensuring the stability and survivability of biotics in various pet food matrices also remains a technical challenge.
Overall, increasing wellness awareness and demand for microbiome-focused nutrition present substantial growth opportunities for pet biotics manufacturers to gain a significant share in the market.
“Probiotic type is expected to hold a dominant market share during the forecast period”
The probiotic types in the pet biotic segments dominate the market due to strong consumer demand for functional nutrition that supports digestive health, immunity, and overall well-being in pets. Scientific evidence demonstrates that probiotic strains, such as Lactobacillus, Bifidobacterium, Bacillus, and Saccharomyces cerevisiae, provide measurable gut and immune benefits, which allows pet food brands to make compelling health claims. Technological advances, such as microencapsulation and strain-specific formulation, help maintain probiotic viability during processing and storage, while ongoing patent activity and product innovation indicate a high commercial value. Despite challenges like strain sensitivity, viability loss during processing, and limited long-term studies, the combination of proven health benefits, consumer awareness, and industry investment has made probiotics a preferred ingredient in dry food, wet food, treats, and supplements.
“Dog segment is expected to hold a strong market share among the pet types in the pet biotics market”
Dogs are expected to dominate the pet type segment in the pet biotics market. This trend is primarily driven by the increasing humanization of pets, where pet owners are more inclined to treat their dogs as family members and invest in their overall health and wellness. Dogs often suffer from common health issues such as joint pain, digestive problems, and skin allergies, which can be managed through targeted nutritional supplements. As a result, the demand for probiotics & prebiotics tailored specifically for dogs, such as those supporting joint health, coat shine, and immune function, is witnessing significant growth.
“North America is expected to dominate the global pet biotics market during the forecast period”
North America dominates the pet biotics market due to a combination of high pet ownership, strong consumer spending on pet health, and advanced industry infrastructure. With high awareness among pet owners in the region of functional nutrition, the demand for probiotics, prebiotics, and postbiotics is strong, as these products can promote gut health, immunity, and overall wellness. The region also has a well-established pet food industry that utilizes advanced manufacturing technologies to maintain the viability of sensitive biotic ingredients. Additionally, North American companies are well-positioned to develop a wide range of pet biotic products, including dry and wet foods, treats, and supplements. Furthermore, supportive regulatory frameworks, robust distribution networks, and considerable investment in R&D and product innovation are expected to drive consumption and market leadership in the pet biotic segment.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the pet biotics market.
- By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45%
- By Designation: Directors – 25%, Managers – 35%, Others – 40%
- By Region: North America – 20%, Europe – 30%, Asia Pacific – 35%, South America – 10%, and Rest of the World – 5%
Prominent companies in the market include ADM (US), Alltech (US), Kerry Group plc (Ireland), International Flavors & Fragrances Inc. (US), dsm-firmenich (Netherlands), Cargill, Incorporated (US), Probi (Sweden), Kemin Industries, Inc. (US), BENEO GmbH (Germany), Ingredion (US), Lallemand Inc. (Canada), Sacco System (Italy), Phileo by Lesaffre (France), Sanzyme Biologics (India), Orffa (Netherlands), BIO-CAT (US), and others.
Research Coverage
This research report categorizes the pet biotics market by type (probiotics, prebiotics, and postbiotics), application (dry food, wet food, supplements, and snacks & treats), pet (dogs, cats, and other pets), function (digestive/gut health, immune modulation, metabolic & weight management, oral & dental health, other functions), manufacturing technology (qualitative) (fermentation, centrifugation & filtration, drying & stabilization, encapsulation & protection, inactivation & cell disruption, formulation & blending, and quality control & storage), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).
The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the pet biotic industry. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the pet biotics market. This report provides a competitive analysis of emerging startups in the pet biotics market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.
Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall pet biotics and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market, providing them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (rising pet humanization and preventive health focus), restraints (heat and moisture sensitivity of microbial strains), opportunities (rising demand for gut-health-focused and functional pet foods), and challenges (supply chain complexity for live microbes) influencing the growth of the pet biotics market
- Product Development/Innovation: Detailed insights into research & development activities and new product launches in the pet biotics market
- Market Development: Comprehensive information about lucrative markets—analysis of pet biotics across varied regions
- Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the pet biotics market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as ADM (US), Alltech (US), Kerry Group plc (Ireland), International Flavors & Fragrances Inc. (US), dsm-firmenich (Netherlands), Cargill, Incorporated (US), Probi (Sweden), Kemin Industries, Inc. (US), BENEO GmbH (Germany), Ingredion (US), Lallemand Inc. (Canada), Sacco System (Italy), Phileo by Lesaffre (France), Sanzyme Biologics (India), Orffa (Netherlands), BIO-CAT (US), and other players in the pet biotics market.
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE AND SEGMENTATION 29
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 30
1.3.2 INCLUSIONS AND EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 31
1.3.4 CURRENCY CONSIDERED 32
1.3.5 UNIT CONSIDERED 32
1.4 STAKEHOLDERS 33
2 EXECUTIVE SUMMARY 34
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 34
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 35
2.3 DISRUPTIVE TRENDS IN PET BIOTICS MARKET 36
2.4 HIGH-GROWTH SEGMENTS 37
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 38
3 PREMIUM INSIGHTS 39
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PET BIOTICS MARKET 39
3.2 PET BIOTICS MARKET, BY PET AND REGION 40
3.3 PET BIOTICS MARKET, BY TYPE 40
3.4 PET BIOTICS MARKET, BY PET 41
3.5 PET BIOTICS MARKET, BY APPLICATION 41
3.6 PET BIOTICS MARKET, BY FORM 41
3.7 PET BIOTICS MARKET, BY COUNTRY 42
4 MARKET OVERVIEW 43
4.1 INTRODUCTION 43
4.2 MARKET DYNAMICS 44
4.2.1 DRIVERS 44
4.2.1.1 Surge in pet adoption rates 44
4.2.1.2 Rise in pet humanization and focus on preventive health 45
4.2.1.3 Growing veterinary recommendations and clinical backing 45
4.2.1.4 Premiumization and functional food trends 46
4.2.2 RESTRAINTS 47
4.2.2.1 Heat and moisture sensitivity of probiotic strains 47
4.2.2.2 Shelf-life viability concerns 47
4.2.3 OPPORTUNITIES 48
4.2.3.1 Innovation in ingredient formulation 48
4.2.3.2 Rising demand for gut-health-focused and functional pet foods 49
4.2.3.3 Increase in pet expenditure with substantial increase in pet food expenditure 49
4.2.3.4 Increase in urban pet lifestyle experiences: Pet cafés, rentals, and pet-friendly travel 50
4.2.4 CHALLENGES 51
4.2.4.1 Supply chain complexity for live microbes 51
4.2.4.2 Competition from alternative digestive health solutions 51
4.3 UNMET NEEDS AND WHITE SPACES 52
4.3.1 UNMET NEEDS IN PET BIOTICS MARKET 52
4.3.2 WHITE SPACE OPPORTUNITIES – SYNBIOTIC (COMBINATION OF PROBIOTICS & PREBIOTICS) 53
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53
4.4.1 INTERCONNECTED MARKETS 53
4.4.2 CROSS-SECTOR OPPORTUNITIES 54
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 55
4.5.1 KEY MOVES AND STRATEGIC FOCUS 55
5 INDUSTRY TRENDS 56
5.1 PORTER’S FIVE FORCES ANALYSIS 56
5.1.1 THREAT OF NEW ENTRANTS 57
5.1.2 THREAT OF SUBSTITUTES 57
5.1.3 BARGAINING POWER OF SUPPLIERS 57
5.1.4 BARGAINING POWER OF BUYERS 58
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 58
5.2 MACROECONOMICS OUTLOOK 58
5.2.1 INTRODUCTION 58
5.2.2 SHIFT TOWARD PREVENTIVE PET HEALTH THROUGH SUPPLEMENT ADOPTION 58
5.2.3 EXPANSION OF PET INSURANCE COVERAGE GLOBALLY 59
5.2.4 ECO-CONSCIOUS PET OWNERSHIP DRIVING DEMAND FOR BIOTIC-BASED PET PRODUCTS 60
5.3 VALUE CHAIN ANALYSIS 61
5.3.1 RESEARCH & DEVELOPMENT 62
5.3.2 SOURCING 62
5.3.3 PRODUCTION & PROCESSING 62
5.3.4 DISTRIBUTION 62
5.3.5 MARKETING & SALES 62
5.3.6 END USERS 63
5.4 ECOSYSTEM ANALYSIS 63
5.4.1 DEMAND SIDE 63
5.4.2 SUPPLY SIDE 63
5.5 PRICING ANALYSIS 65
5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY LIVESTOCK 65
5.5.2 AVERAGE SELLING PRICE TREND OF PET BIOTICS, BY REGION, 2021–2024 66
5.6 TRADE ANALYSIS 66
5.6.1 IMPORT SCENARIO OF HS CODE 3002 66
5.6.2 EXPORT SCENARIO OF HS CODE 3002 68
5.7 KEY CONFERENCES AND EVENTS, 2025–2026 69
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 69
5.9 INVESTMENT AND FUNDING SCENARIO 70
5.10 CASE STUDY ANALYSIS 70
5.10.1 STABILIZED PLANT-BASED PROBIOTIC INTEGRATION BY A&B INGREDIENTS TO ENHANCE DIGESTIVE AND SKIN HEALTH IN DOGS 70
5.10.2 PROBIOWORLD’S DUAL-ACTION PET BIOTIC FORMULATION FOR DENTAL AND GUT HEALTH ENHANCEMENT 71
5.10.3 CHR. HANSEN (PART OF NOVONESIS GROUP) – PIONEERING SCIENCE-BASED PROBIOTICS PORTFOLIO FOR EVERY PET LIFE STAGE 71
5.11 IMPACT OF 2025 US TARIFF – PET BIOTICS MARKET 72
5.11.1 INTRODUCTION 72
5.11.2 KEY TARIFF RATES 73
5.11.3 PRICE IMPACT ANALYSIS 74
5.11.4 IMPACT ON COUNTRIES/REGIONS 74
5.11.4.1 US 74
5.11.4.2 Europe 75
5.11.4.3 Asia Pacific 75
5.11.5 IMPACT ON END-USE INDUSTRIES 75
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 76
6.1 TECHNOLOGY ANALYSIS 76
6.1.1 KEY TECHNOLOGIES 76
6.1.1.1 Fermentation 76
6.1.1.2 Filtration 77
6.1.1.3 Freeze-drying (Lyophilization) 77
6.1.1.4 Microencapsulation and nanoencapsulation 77
6.1.2 COMPLEMENTARY TECHNOLOGIES 78
6.1.2.1 IoT-based fermentation monitoring 78
6.1.2.2 Enzymatic hydrolysis 79
6.1.3 ADJACENT TECHNOLOGIES 79
6.1.3.1 Genome-scale metabolic modeling 79
6.1.3.2 Bioinformatics 79
6.1.3.3 Digital fermentation control 79
6.1.4 TECHNOLOGY/PRODUCT ROADMAP 80
6.1.4.1 Short-term | Foundation & Early Commercialization 80
6.1.4.2 Mid-term | Expansion & Standardization 80
6.1.4.3 Long-term | Mass Commercialization & Disruption 80
6.2 PATENT ANALYSIS 81
6.3 FUTURE APPLICATIONS 83
6.3.1 PSYCHOBIOTICS FOR BEHAVIORAL AND COGNITIVE HEALTH IN PETS 83
6.3.2 SYNBIOTICS AS NEXT-GENERATION GUT HEALTH SOLUTIONS IN PETS 84
6.3.3 ENGINEERED/BREED-PRECISION PROBIOTIC STRAINS FOR PET HEALTH 84
6.3.4 MICROBIOME-LINKED DIAGNOSTIC TOOLS FOR TARGETED PET BIOTIC THERAPIES 85
6.3.5 SPORE-BASED PROBIOTICS FOR SHELF-STABLE, HIGH-TEMPERATURE PET FOOD PROCESSING 86
6.4 IMPACT OF GEN AI ON PET FOOD INDUSTRY 87
6.4.1 TOP USE CASES AND MARKET POTENTIAL 87
6.4.2 BEST PRACTICE OF GEN AI IN PET FOOD INDUSTRY 88
6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN PET INDUSTRY 88
6.4.3.1 CanBiocin’s data-intelligent approach to enhancing fermentation efficiency and yield 88
6.4.3.2 Harmonizing formulation systems: PPF’s pan-European implementation of BESTMIX Recipe Management 89
6.4.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 90
6.4.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PET BIOTICS 90
6.4.6 IMPACT OF AI/GENERATIVE AI ON PET BIOTICS MARKET 90
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 91
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 92
7.1 REGIONAL REGULATIONS AND COMPLIANCE 92
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
7.1.2 INDUSTRY STANDARDS 94
7.1.3 LABELING REQUIREMENTS AND CLAIMS 95
7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5–10 YEARS 96
7.1.4.1 Mandatory validation of CFU viability & functional claims 96
7.1.4.2 Global harmonization of pet biotics ingredient approvals 96
7.1.4.3 Enhanced safety and antimicrobial-resistance (AMR) risk evaluation 96
7.1.4.4 Digital labeling, data transparency, and smart packaging requirements 96
7.2 SUSTAINABILITY INITIATIVES 96
7.2.1 SUSTAINABLE SOURCING 97
7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 97
7.2.3 CIRCULAR ECONOMY APPROACHES 98
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 98
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 99
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 100
8.1 DECISION-MAKING PROCESS 100
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 102
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 102
8.2.2 BUYING CRITERIA 103
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 103
8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES 104
8.5 MARKET PROFITABILITY 105
8.6 REVENUE POTENTIAL 106
8.6.1 COST DYNAMICS 106
8.6.2 MARGIN OPPORTUNITIES, BY INGREDIENT SOURCE 107
9 PET BIOTICS MARKET, BY TYPE 108
9.1 INTRODUCTION 109
9.2 PROBIOTICS 111
9.2.1 BACTERIA 113
9.2.1.1 Driving Digestive Strength and Immune Resilience in Companion Animals Through Science-backed Bacterial Probiotics 113
9.2.1.2 Lactobacillus 115
9.2.1.3 Bifidobacterium 115
9.2.1.4 Enterococcus 116
9.2.1.5 Bacillus 117
9.2.1.6 Streptococcus thermophilus 118
9.2.2 YEAST & FUNGI 119
9.2.2.1 Advanced yeast solutions transforming digestive wellness in companion animals 119
9.2.2.2 Saccharomyces cerevisiae 121
9.2.2.3 Saccharomyces Boulardii 122
9.3 PREBIOTICS 123
9.3.1 STRENGTHENING GUT ECOLOGY FOR LONG-TERM VITALITY AND IMMUNE STRENGTH 123
9.3.2 OLIGOSACCHARIDES 125
9.3.2.1 Fructooligosaccharides (FOS) 127
9.3.2.2 Mannanoligosaccharides (MOS) 127
9.3.2.3 Galactooligosaccharides (GOS) 128
9.3.3 INULIN 129
9.3.4 POLYDEXTROSE 130
9.3.5 OTHER PREBIOTIC TYPES 131
9.4 POSTBIOTICS 132
9.4.1 PREMIUM POSTBIOTIC SOLUTIONS DESIGNED FOR STABILITY, SAFETY, AND SUPERIOR PERFORMANCE 132
9.4.2 BACTERIA 134
9.4.2.1 Lactobacillus 135
9.4.2.2 Bifidobacterium 135
9.4.2.3 Other bacteria 136
9.5 YEAST & FUNGI 136
9.5.1 FUNCTIONAL YEAST INNOVATION SHAPING FUTURE OF PET WELLNESS 136
9.5.2 SACCHAROMYCES CEREVISIAE 138
9.5.3 SACCHAROMYCES BOULARDII 138
10 PET BIOTICS MARKET, BY APPLICATION 139
10.1 INTRODUCTION 140
10.1.1 DRY FOOD 141
10.1.1.1 Long-lasting gut health protection in every crunchy bite 141
10.1.2 WET FOOD 142
10.1.2.1 Smooth integration, stronger digestion—biotics that thrive in wet formats 142
10.1.3 SUPPLEMENTS 143
10.1.3.1 Premium supplement solutions for proactive pet well-being 143
10.1.4 SNACKS & TREATS 145
10.1.4.1 Reward with purpose—treats enriched with biotics for everyday vitality 145
11 PET BIOTICS MARKET, BY FORM 147
11.1 INTRODUCTION 148
11.2 DRY 149
11.2.1 STABLE, SCALABLE, AND SCIENCE-FORWARD—DRY BIOTICS POWERING NEXT-GENERATION PET WELLNESS 149
11.3 LIQUID 150
11.3.1 EASE OF INCORPORATION, PRECISION DOSING, AND SMOOTH DELIVERY FOR SENSITIVE AND RECOVERING PETS TO DRIVE DEMAND 150
12 PET BIOTICS MARKET, BY PET 152
12.1 INTRODUCTION 153
12.2 DOGS 154
12.2.1 DAILY GUT AND IMMUNE SUPPORT FOR HEALTHIER, HAPPIER CANINE COMPANIONS 154
12.3 CATS 155
12.3.1 GENTLE, TARGETED GUT SUPPORT CRAFTED FOR SENSITIVE FELINE DIGESTION 155
12.4 OTHER PETS 156
13 PET BIOTICS MARKET, BY FUNCTION 157
13.1 INTRODUCTION 158
13.2 DIGESTIVE/GUT HEALTH 159
13.3 IMMUNE MODULATION 160
13.4 METABOLIC & WEIGHT MANAGEMENT 160
13.5 ORAL & DENTAL HEALTH 160
13.6 OTHER FUNCTIONS 161
14 PET BIOTICS MARKET, BY MANUFACTURING TECHNOLOGY 162
14.1 INTRODUCTION 162
14.2 FERMENTATION 162
14.3 CENTRIFUGATION & FILTRATION 163
14.4 DRYING & STABILIZATION 164
14.5 ENCAPSULATION & PROTECTION 165
14.6 INACTIVATION & CELL DISRUPTION 165
14.7 FORMULATION & BLENDING 166
14.8 QUALITY CONTROL & STORAGE 166
15 PET BIOTICS MARKET, BY REGION 168
15.1 INTRODUCTION 169
15.2 NORTH AMERICA 171
15.2.1 US 175
15.2.1.1 Global hub for pet biotics innovation, powered by presence of leading ingredient and technology companies 175
15.2.2 CANADA 177
15.2.2.1 Rising hub for functional pet nutrition and microbiome wellness 177
15.2.3 MEXICO 179
15.2.3.1 Rising market for digestive wellness and microbiome nutrition 179
15.3 EUROPE 180
15.3.1 GERMANY 183
15.3.1.1 Strong consumer demand for pet biotics to drive market 183
15.3.2 UK 185
15.3.2.1 Expanding companion-animal base to drive market 185
15.3.3 FRANCE 187
15.3.3.1 Rising health concerns to strengthen demand for pet biotics 187
15.3.4 ITALY 188
15.3.4.1 Growing pet humanization and premium nutrition trends to fuel market 188
15.3.5 SPAIN 189
15.3.5.1 Wellness-driven pet culture to accelerate pet biotics adoption 189
15.3.6 REST OF EUROPE 191
15.4 ASIA PACIFIC 192
15.4.1 CHINA 196
15.4.1.1 Rapid urban growth and wellness priorities to drive market 196
15.4.2 JAPAN 198
15.4.2.1 Health, premiumization, and sustainability to drive demand for pet biotics 198
15.4.3 INDIA 199
15.4.3.1 Consumer shift toward functional and preventive nutrition products to drive market 199
15.4.4 AUSTRALIA & NEW ZEALAND 201
15.4.4.1 Demand for premium and functional nutrition to support market growth 201
15.4.5 REST OF ASIA PACIFIC 202
15.5 SOUTH AMERICA 204
15.5.1 BRAZIL 207
15.5.1.1 Expanding pet market to drive demand for pet biotics 207
15.5.2 ARGENTINA 208
15.5.2.1 Steady pet market growth to fuel pet biotics demand 208
15.5.3 REST OF SOUTH AMERICA 209
15.6 REST OF THE WORLD 211
15.6.1 MIDDLE EAST 214
15.6.1.1 Rising pet humanization and urbanization to fuel demand for pet biotics 214
15.6.2 AFRICA 215
15.6.2.1 Growing focus on pet health to drive market 215
16 COMPETITIVE LANDSCAPE 217
16.1 OVERVIEW 217
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 217
16.3 REVENUE ANALYSIS 219
16.4 MARKET SHARE ANALYSIS 219
16.5 COMPANY VALUATION AND FINANCIAL METRICS 222
16.5.1 COMPANY VALUATION 222
16.5.2 FINANCIAL METRICS 222
16.6 BRAND/PRODUCT COMPARISON 223
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 224
16.7.1 STARS 224
16.7.2 EMERGING LEADERS 225
16.7.3 PERVASIVE PLAYERS 225
16.7.4 PARTICIPANTS 225
16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 227
16.7.5.1 Company footprint 227
16.7.5.2 Regional footprint 227
16.7.5.3 Type footprint 228
16.7.5.4 Pet footprint 228
16.7.5.5 Application footprint 229
16.7.5.6 Form footprint 230
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 230
16.8.1 PROGRESSIVE COMPANIES 230
16.8.2 RESPONSIVE COMPANIES 231
16.8.3 DYNAMIC COMPANIES 231
16.8.4 STARTING BLOCKS 231
16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 232
16.9 COMPETITIVE SCENARIO AND TRENDS 234
16.9.1 PRODUCT LAUNCHES 234
16.9.2 DEALS 234
16.9.3 EXPANSIONS 237
16.9.4 OTHER DEVELOPMENTS 238
17 COMPANY PROFILES 239
17.1 KEY PLAYERS 239
17.1.1 ADM 239
17.1.1.1 Business overview 239
17.1.1.2 Products/Services/Solutions offered 240
17.1.1.3 Recent developments 241
17.1.1.3.1 Expansions 241
17.1.1.4 MnM view 242
17.1.1.4.1 Key strengths 242
17.1.1.4.2 Strategic choices 242
17.1.1.4.3 Weaknesses & competitive threats 242
17.1.2 ALLTECH (US) 243
17.1.2.1 Business overview 243
17.1.2.2 Products/Services/Solutions offered 243
17.1.2.3 Recent developments 245
17.1.2.3.1 Product launches 245
17.1.2.4 MnM view 245
17.1.2.4.1 Key strengths 245
17.1.2.4.2 Strategic choices 245
17.1.2.4.3 Weaknesses & competitive threats 245
17.1.3 KERRY GROUP PLC 246
17.1.3.1 Business overview 246
17.1.3.2 Products/Services/Solutions offered 247
17.1.3.3 Recent developments 248
17.1.3.3.1 Deals 248
17.1.3.4 MnM view 248
17.1.3.4.1 Key strengths 248
17.1.3.4.2 Strategic choices 248
17.1.3.4.3 Weaknesses & competitive threats 249
17.1.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 250
17.1.4.1 Business overview 250
17.1.4.2 Products/Services/Solutions offered 251
17.1.4.3 Recent developments 251
17.1.4.4 MnM view 252
17.1.4.4.1 Key strengths 252
17.1.4.4.2 Strategic choices 252
17.1.4.4.3 Weaknesses & competitive threats 252
17.1.5 DSM-FIRMENICH 253
17.1.5.1 Business overview 253
17.1.5.2 Products/Services/Solutions offered 255
17.1.5.3 Recent developments 255
17.1.5.3.1 Deals 255
17.1.5.4 MnM view 256
17.1.5.4.1 Key strengths 256
17.1.5.4.2 Strategic choices 256
17.1.5.4.3 Weaknesses & competitive threats 256
17.1.6 CARGILL, INCORPORATED 257
17.1.6.1 Business overview 257
17.1.6.2 Products/Services/Solutions offered 258
17.1.6.3 Recent developments 259
17.1.6.3.1 Deals 259
17.1.6.3.2 Expansions 259
17.1.6.3.3 Other developments 260
17.1.6.4 MnM view 260
17.1.6.4.1 Key strengths 260
17.1.6.4.2 Strategic choices 261
17.1.6.4.3 Weaknesses & competitive threats 261
17.1.7 PROBI 262
17.1.7.1 Business overview 262
17.1.7.2 Products/Services/Solutions offered 263
17.1.7.3 Recent developments 264
17.1.7.3.1 Deals 264
17.1.7.4 MnM view 264
17.1.8 INGREDION (US) 265
17.1.8.1 Business overview 265
17.1.8.2 Products/Services/Solutions offered 266
17.1.8.3 Recent developments 266
17.1.8.4 MnM view 266
17.1.9 KEMIN INDUSTRIES, INC. 267
17.1.9.1 Business overview 267
17.1.9.2 Products/Services/Solutions offered 267
17.1.9.3 MnM view 267
17.1.10 BENEO GMBH 268
17.1.10.1 Business overview 268
17.1.10.2 Products/Services/Solutions offered 268
17.1.10.3 Recent developments 269
17.1.10.3.1 Other Developments 269
17.1.10.4 MnM view 269
17.1.11 PHILEO BY LESAFFRE 270
17.1.11.1 Business overview 270
17.1.11.2 Products/Services/Solutions offered 270
17.1.11.3 Recent developments 271
17.1.11.3.1 Deals 271
17.1.11.4 MnM view 271
17.1.12 LALLEMAND INC. 272
17.1.12.1 Business overview 272
17.1.12.2 Products/Services/Solutions offered 272
17.1.12.3 Recent developments 274
17.1.12.4 MnM view 274
17.1.13 SACCO SYSTEM 275
17.1.13.1 Business overview 275
17.1.13.2 Products/Services/Solutions offered 275
17.1.13.3 Recent developments 276
17.1.13.4 MnM view 276
17.1.14 SANZYME BIOLOGICS 277
17.1.14.1 Business overview 277
17.1.14.2 Products/Services/Solutions offered 277
17.1.14.3 Recent developments 278
17.1.14.4 MnM view 278
17.1.15 ORFFA 279
17.1.15.1 Business overview 279
17.1.15.2 Products/Services/Solutions offered 279
17.1.15.3 Recent developments 280
17.1.15.4 MnM view 280
17.2 STARTUPS/SMES 281
17.2.1 SYNBIO TECH INC. 281
17.2.1.1 Business overview 281
17.2.1.2 Products/Services/Solutions offered 281
17.2.1.3 Recent developments 282
17.2.1.4 MnM view 283
17.2.2 CANBIOCIN INC. 284
17.2.2.1 Business overview 284
17.2.2.2 Products/Services/Solutions offered 284
17.2.2.3 Recent developments 285
17.2.2.3.1 Deals 285
17.2.2.4 MnM view 285
17.2.3 BIO-CAT 286
17.2.3.1 Business overview 286
17.2.3.2 Products/Services/Solutions offered 286
17.2.3.3 Recent developments 287
17.2.3.3.1 Deals 287
17.2.3.4 MnM view 287
17.2.4 SPECIALTY ENZYMES & PROBIOTICS 288
17.2.4.1 Business overview 288
17.2.4.2 Products/Services/Solutions offered 288
17.2.4.3 Recent developments 289
17.2.4.3.1 Product launches 289
17.2.4.4 MnM view 289
17.2.5 CREATIVE ENZYMES 290
17.2.5.1 Business overview 290
17.2.5.2 Products/Services/Solutions offered 290
17.2.5.3 Recent developments 290
17.2.5.4 MnM view 291
17.2.6 VERB BIOTICS 292
17.2.7 BIOTENOVA SDN. BHD. 293
17.2.8 BIOPROX HEALTHCARE 294
17.2.9 PELLUCID LIFESCIENCES PVT. LTD 295
17.2.10 HOLLISON, LLC. (US) 296
18 RESEARCH METHODOLOGY 297
18.1 RESEARCH DATA 297
18.1.1 SECONDARY DATA 297
18.1.1.1 Key data from secondary sources 298
18.1.2 PRIMARY DATA 298
18.1.2.1 Key data from primary sources 298
18.1.2.2 Breakdown of primary profiles 299
18.1.2.3 Key insights from industry experts 300
18.2 MARKET SIZE ESTIMATION 300
18.2.1 TOP-DOWN APPROACH 301
18.2.2 SUPPLY-SIDE ANALYSIS 302
18.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 303
18.3 DATA TRIANGULATION AND MARKET BREAKUP 304
18.4 RESEARCH ASSUMPTIONS 305
18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 305
19 ADJACENT & RELATED MARKETS 306
19.1 INTRODUCTION 306
19.2 STUDY LIMITATIONS 306
19.3 PET SUPPLEMENTS MARKET 306
19.3.1 MARKET DEFINITION 306
19.3.2 MARKET OVERVIEW 307
19.4 PET FOOD INGREDIENTS MARKET 307
19.4.1 MARKET DEFINITION 307
19.4.2 MARKET OVERVIEW 308
20 APPENDIX 309
20.1 DISCUSSION GUIDE 309
20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 317
20.3 CUSTOMIZATION OPTIONS 319
20.4 RELATED REPORTS 319
LIST OF TABLES
TABLE 1 USD EXCHANGE RATES, 2020–2024 32
TABLE 2 KEY MOVES AND STRATEGIC FOCUS 55
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON PET BIOTICS MARKET 57
TABLE 4 ROLES OF COMPANIES IN PET BIOTICS MARKET ECOSYSTEM 64
TABLE 5 IMPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS) 67
TABLE 6 EXPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS) 68
TABLE 7 PET BIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 69
TABLE 8 US-ADJUSTED RECIPROCAL TARIFF RATES 73
TABLE 9 LIST OF MAJOR PATENTS PERTAINING TO PET BIOTICS MARKET, 2020–2025 81
TABLE 10 TOP USE CASES AND MARKET POTENTIAL 87
TABLE 11 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 90
TABLE 12 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 91
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 16 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 17 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 18 GLOBAL INDUSTRY STANDARDS IN PET BIOTICS MARKET 95
TABLE 19 LABELING REQUIREMENTS AND CLAIMS IN PET BIOTICS MARKET 95
TABLE 20 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PET BIOTICS MARKET 99
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 102
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 103
TABLE 23 UNMET NEEDS IN PET BIOTICS MARKET, BY APPLICATION INDUSTRY
(SUPPLY CHAIN) 104
TABLE 24 COST DYNAMICS IN PET BIOTICS MARKET 106
TABLE 25 MARGIN OPPORTUNITIES IN PET BIOTICS MARKET, BY INGREDIENT SOURCE 107
TABLE 26 PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 110
TABLE 27 PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 110
TABLE 28 PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 110
TABLE 29 PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 110
TABLE 30 PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 111
TABLE 31 PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 112
TABLE 32 PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS) 112
TABLE 33 PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS) 112
TABLE 34 PROBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 112
TABLE 35 PROBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 113
TABLE 36 BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2021–2024 (USD MILLION) 113
TABLE 37 BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2025–2030 (USD MILLION) 114
TABLE 38 BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY SUBTYPE,
2021–2024 (USD MILLION) 114
TABLE 39 BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY SUBTYPE,
2025–2030 (USD MILLION) 114
TABLE 40 LACTOBACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2021–2024 (USD MILLION) 115
TABLE 41 LACTOBACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2025–2030 (USD MILLION) 115
TABLE 42 BIFIDOBACTERIUM: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2021–2024 (USD MILLION) 116
TABLE 43 BIFIDOBACTERIUM: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2025–2030 (USD MILLION) 116
TABLE 44 ENTEROCOCCUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2021–2024 (USD MILLION) 117
TABLE 45 ENTEROCOCCUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2025–2030 (USD MILLION) 117
TABLE 46 BACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2021–2024 (USD MILLION) 118
TABLE 47 BACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION,
2025–2030 (USD MILLION) 118
TABLE 48 STREPTOCOCCUS THERMOPHILUS: PET BIOTICS MARKET FOR PROBIOTICS,
BY REGION, 2021–2024 (USD MILLION) 119
TABLE 49 STREPTOCOCCUS THERMOPHILUS: PET BIOTICS MARKET FOR PROBIOTICS,
BY REGION, 2025–2030 (USD MILLION) 119
TABLE 50 YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 120
TABLE 51 YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 120
TABLE 52 YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 120
TABLE 53 YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 120
TABLE 54 SACCHAROMYCES CEREVISIAE: PET BIOTICS MARKET FOR YEAST & FUNGI,
BY REGION, 2021–2024 (USD MILLION) 121
TABLE 55 SACCHAROMYCES CEREVISIAE: PET BIOTICS MARKET FOR YEAST & FUNGI,
BY REGION, 2025–2030 (USD MILLION) 121
TABLE 56 SACCHAROMYCES BOULARDII: PET BIOTICS MARKET FOR YEAST & FUNGI,
BY REGION, 2021–2024 (USD MILLION) 122
TABLE 57 SACCHAROMYCES BOULARDII: PET BIOTICS MARKET FOR YEAST & FUNGI,
BY REGION, 2025–2030 (USD MILLION) 122
TABLE 58 PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 123
TABLE 59 PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 123
TABLE 60 PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS) 124
TABLE 61 PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS) 124
TABLE 62 PREBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 124
TABLE 63 PREBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 125
TABLE 64 OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2021–2024 (USD MILLION) 125
TABLE 65 OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2025–2030 (USD MILLION) 126
TABLE 66 OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY TYPE,
2021–2024 (USD MILLION) 126
TABLE 67 OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY TYPE,
2025–2030 (USD MILLION) 126
TABLE 68 FOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2021–2024 (USD MILLION) 127
TABLE 69 FOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2025–2030 (USD MILLION) 127
TABLE 70 MOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2021–2024 (USD MILLION) 128
TABLE 71 MOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2025–2030 (USD MILLION) 128
TABLE 72 GOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2021–2024 (USD MILLION) 128
TABLE 73 GOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2025–2030 (USD MILLION) 129
TABLE 74 INULIN: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2021–2024 (USD MILLION) 129
TABLE 75 INULIN: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2025–2030 (USD MILLION) 130
TABLE 76 POLYDEXTROSE: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2021–2024 (USD MILLION) 130
TABLE 77 POLYDEXTROSE: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2025–2030 (USD MILLION) 131
TABLE 78 OTHER PREBIOTICS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2021–2024 (USD MILLION) 131
TABLE 79 OTHER PREBIOTICS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION,
2025–2030 (USD MILLION) 132
TABLE 80 POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 132
TABLE 81 POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 133
TABLE 82 POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS) 133
TABLE 83 POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS) 133
TABLE 84 POSTBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 134
TABLE 85 POSTBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 134
TABLE 86 BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY REGION,
2021–2024 (USD MILLION) 134
TABLE 87 BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY REGION,
2025–2030 (USD MILLION) 135
TABLE 88 BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY TYPE,
2021–2024 (USD MILLION) 135
TABLE 89 BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY TYPE,
2025–2030 (USD MILLION) 135
TABLE 90 YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 137
TABLE 91 YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 137
TABLE 92 YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 137
TABLE 93 YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 137
TABLE 94 PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 140
TABLE 95 PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 141
TABLE 96 DRY FOOD: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 142
TABLE 97 DRY FOOD: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 142
TABLE 98 WET FOOD: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 143
TABLE 99 WET FOOD: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 143
TABLE 100 SUPPLEMENTS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 144
TABLE 101 SUPPLEMENTS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 144
TABLE 102 SNACKS & TREATS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 145
TABLE 103 SNACKS & TREATS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 146
TABLE 104 PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 148
TABLE 105 PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 148
TABLE 106 DRY: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 149
TABLE 107 DRY: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 150
TABLE 108 LIQUID: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 151
TABLE 109 LIQUID: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 151
TABLE 110 PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 154
TABLE 111 PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 154
TABLE 112 DOGS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 154
TABLE 113 DOGS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 155
TABLE 114 CATS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 155
TABLE 115 CATS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 156
TABLE 116 OTHER PETS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 156
TABLE 117 OTHER PETS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 156
TABLE 118 PET BIOTICS MARKET, BY FUNCTION, 2021–2024 (USD MILLION) 159
TABLE 119 PET BIOTICS MARKET, BY FUNCTION, 2025–2030 (USD MILLION) 159
TABLE 120 PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 170
TABLE 121 PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 170
TABLE 122 PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS) 170
TABLE 123 PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS) 171
TABLE 124 NORTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 172
TABLE 125 NORTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 172
TABLE 126 NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 173
TABLE 127 NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 173
TABLE 128 NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 173
TABLE 129 NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 173
TABLE 130 NORTH AMERICA: PET BIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 174
TABLE 131 NORTH AMERICA: PET BIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 174
TABLE 132 NORTH AMERICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 174
TABLE 133 NORTH AMERICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 174
TABLE 134 NORTH AMERICA: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 175
TABLE 135 NORTH AMERICA: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 175
TABLE 136 US: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 176
TABLE 137 US: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 176
TABLE 138 US: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 176
TABLE 139 US: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 176
TABLE 140 CANADA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 178
TABLE 141 CANADA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 178
TABLE 142 CANADA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 178
TABLE 143 CANADA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 178
TABLE 144 MEXICO: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 179
TABLE 145 MEXICO: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 179
TABLE 146 MEXICO: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 179
TABLE 147 MEXICO: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 180
TABLE 148 EUROPE: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 180
TABLE 149 EUROPE: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 181
TABLE 150 EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 181
TABLE 151 EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 181
TABLE 152 EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 181
TABLE 153 EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 182
TABLE 154 EUROPE: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 182
TABLE 155 EUROPE: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 182
TABLE 156 EUROPE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 182
TABLE 157 EUROPE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 183
TABLE 158 EUROPE: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 183
TABLE 159 EUROPE: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 183
TABLE 160 GERMANY: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 184
TABLE 161 GERMANY: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 184
TABLE 162 GERMANY: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 184
TABLE 163 GERMANY: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 185
TABLE 164 UK: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 186
TABLE 165 UK: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 186
TABLE 166 UK: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 186
TABLE 167 UK: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 186
TABLE 168 FRANCE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 187
TABLE 169 FRANCE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 187
TABLE 170 FRANCE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 187
TABLE 171 FRANCE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 188
TABLE 172 ITALY: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 188
TABLE 173 ITALY: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 189
TABLE 174 ITALY: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 189
TABLE 175 ITALY: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 189
TABLE 176 SPAIN: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 190
TABLE 177 SPAIN: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 190
TABLE 178 SPAIN: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 190
TABLE 179 SPAIN: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 191
TABLE 180 REST OF EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 191
TABLE 181 REST OF EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 191
TABLE 182 REST OF EUROPE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 192
TABLE 183 REST OF EUROPE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 192
TABLE 184 ASIA PACIFIC: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 193
TABLE 185 ASIA PACIFIC: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 194
TABLE 186 ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 194
TABLE 187 ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 194
TABLE 188 ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 194
TABLE 189 ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 195
TABLE 190 ASIA PACIFIC: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 195
TABLE 191 ASIA PACIFIC: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 195
TABLE 192 ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 195
TABLE 193 ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 196
TABLE 194 ASIA PACIFIC: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 196
TABLE 195 ASIA PACIFIC: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 196
TABLE 196 CHINA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 197
TABLE 197 CHINA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 197
TABLE 198 CHINA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 197
TABLE 199 CHINA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 198
TABLE 200 JAPAN: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 198
TABLE 201 JAPAN: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 199
TABLE 202 JAPAN: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 199
TABLE 203 JAPAN: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 199
TABLE 204 INDIA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 200
TABLE 205 INDIA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 200
TABLE 206 INDIA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 200
TABLE 207 INDIA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 201
TABLE 208 AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY TYPE,
2021–2024 (USD MILLION) 201
TABLE 209 AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY TYPE,
2025–2030 (USD MILLION) 202
TABLE 210 AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY PET,
2021–2024 (USD MILLION) 202
TABLE 211 AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY PET,
2025–2030 (USD MILLION) 202
TABLE 212 REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE,
2021–2024 (USD MILLION) 203
TABLE 213 REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE,
2025–2030 (USD MILLION) 203
TABLE 214 REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 203
TABLE 215 REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 203
TABLE 216 SOUTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 204
TABLE 217 SOUTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 204
TABLE 218 SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 204
TABLE 219 SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 205
TABLE 220 SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 205
TABLE 221 SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 205
TABLE 222 SOUTH AMERICA: PET BIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 205
TABLE 223 SOUTH AMERICA: PET BIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 206
TABLE 224 SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 206
TABLE 225 SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 206
TABLE 226 SOUTH AMERICA: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 206
TABLE 227 SOUTH AMERICA: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 207
TABLE 228 BRAZIL: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 207
TABLE 229 BRAZIL: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 207
TABLE 230 BRAZIL: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 208
TABLE 231 BRAZIL: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 208
TABLE 232 ARGENTINA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 208
TABLE 233 ARGENTINA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 209
TABLE 234 ARGENTINA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 209
TABLE 235 ARGENTINA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 209
TABLE 236 REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE,
2021–2024 (USD MILLION) 210
TABLE 237 REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE,
2025–2030 (USD MILLION) 210
TABLE 238 REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY PET,
2021–2024 (USD MILLION) 210
TABLE 239 REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY PET,
2025–2030 (USD MILLION) 210
TABLE 240 REST OF THE WORLD: PET BIOTICS MARKET, BY REGION,
2021–2024 (USD MILLION) 211
TABLE 241 REST OF THE WORLD: PET BIOTICS MARKET, BY REGION,
2025–2030 (USD MILLION) 211
TABLE 242 REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 211
TABLE 243 REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 212
TABLE 244 REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 212
TABLE 245 REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 212
TABLE 246 REST OF THE WORLD: PET BIOTICS MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 212
TABLE 247 REST OF THE WORLD: PET BIOTICS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 213
TABLE 248 REST OF THE WORLD: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 213
TABLE 249 REST OF THE WORLD: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 213
TABLE 250 REST OF THE WORLD: PET BIOTICS MARKET, BY FORM,
2021–2024 (USD MILLION) 213
TABLE 251 REST OF THE WORLD: PET BIOTICS MARKET, BY FORM,
2025–2030 (USD MILLION) 214
TABLE 252 MIDDLE EAST: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 214
TABLE 253 MIDDLE EAST: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 214
TABLE 254 MIDDLE EAST: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 215
TABLE 255 MIDDLE EAST: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 215
TABLE 256 AFRICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 215
TABLE 257 AFRICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 216
TABLE 258 AFRICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 216
TABLE 259 AFRICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 216
TABLE 260 OVERVIEW OF STRATEGIES ADOPTED BY KEY PET BIOTICS MARKET PLAYERS 217
TABLE 261 PET BIOTICS MARKET: MARKET SHARE ANALYSIS, 2024 220
TABLE 262 PET BIOTICS MARKET: REGIONAL FOOTPRINT, 2024 227
TABLE 263 PET BIOTICS MARKET: TYPE FOOTPRINT, 2024 228
TABLE 264 PET BIOTICS MARKET: PET FOOTPRINT, 2024 228
TABLE 265 PET BIOTICS MARKET: APPLICATION FOOTPRINT, 2024 229
TABLE 266 PET BIOTICS MARKET: FORM FOOTPRINT, 2024 230
TABLE 267 PET BIOTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 232
TABLE 268 PET BIOTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 233
TABLE 269 PET BIOTICS MARKET: PRODUCT LAUNCHES, APRIL 2022–SEPTEMBER 2023 234
TABLE 270 PET BIOTICS MARKET: DEALS, JULY 2023 – OCTOBER 2025 234
TABLE 271 PET BIOTICS MARKET: EXPANSIONS, FEBRUARY 2020–NOVEMBER 2025 237
TABLE 272 PET BIOTICS MARKET: OTHER DEVELOPMENTS, NOVEMBER 2024 238
TABLE 273 ADM: BUSINESS OVERVIEW 239
TABLE 274 ADM: PRODUCTS/SERVICES/SOLUTIONS OFFERED 240
TABLE 275 ADM: EXPANSIONS 241
TABLE 276 ALLTECH: COMPANY OVERVIEW 243
TABLE 277 ALLTECH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 243
TABLE 278 ALLTECH: PRODUCT LAUNCHES 245
TABLE 279 KERRY GROUP PLC: COMPANY OVERVIEW 246
TABLE 280 KERRY GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 247
TABLE 281 KERRY GROUP PLC: DEALS 248
TABLE 282 INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY OVERVIEW 250
TABLE 283 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 251
TABLE 284 DSM-FIRMENICH: COMPANY OVERVIEW 253
TABLE 285 DSM-FIRMENICH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 255
TABLE 286 DSM-FIRMENICH: DEALS 255
TABLE 287 CARGILL, INCORPORATED: COMPANY OVERVIEW 257
TABLE 288 CARGILL, INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED 258
TABLE 289 CARGILL, INCORPORATED: DEALS 259
TABLE 290 CARGILL, INCORPORATED: EXPANSIONS 259
TABLE 291 CARGILL, INCORPORATED: OTHER DEVELOPMENTS 260
TABLE 292 PROBI: COMPANY OVERVIEW 262
TABLE 293 PROBI: PRODUCTS/SERVICES/SOLUTIONS OFFERED 263
TABLE 294 PROBI: DEALS 264
TABLE 295 INGREDION: COMPANY OVERVIEW 265
TABLE 296 INGREDION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 266
TABLE 297 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW 267
TABLE 298 KEMIN INDUSTRIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 267
TABLE 299 BENEO GMBH: COMPANY OVERVIEW 268
TABLE 300 BENEO GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 268
TABLE 301 BENEO GMBH: OTHER DEVELOPMENTS 269
TABLE 302 PHILEO BY LESAFFRE: COMPANY OVERVIEW 270
TABLE 303 PHILEO BY LESAFFRE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 270
TABLE 304 PHILEO BY LESAFFRE (FRANCE): DEALS 271
TABLE 305 LALLEMAND INC.: COMPANY OVERVIEW 272
TABLE 306 LALLEMAND INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 272
TABLE 307 LALLEMAND INC.: DEALS 274
TABLE 308 SACCO SYSTEM: COMPANY OVERVIEW 275
TABLE 309 SACCO SYSTEM (ITALY): PRODUCTS/SERVICES/SOLUTIONS OFFERED 275
TABLE 310 SANZYME BIOLOGICS: COMPANY OVERVIEW 277
TABLE 311 SANZYME BIOLOGICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 277
TABLE 312 ORFFA: COMPANY OVERVIEW 279
TABLE 313 ORFFA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 279
TABLE 314 SYNBIO TECH INC.: COMPANY OVERVIEW 281
TABLE 315 SYNBIO TECH INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 281
TABLE 316 SYNBIO TECH INC.: EXPANSION 282
TABLE 317 CANBIOCIN INC.: COMPANY OVERVIEW 284
TABLE 318 CANBIOCIN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 284
TABLE 319 CANBIOCIN INC.: DEALS 285
TABLE 320 BIO-CAT (US): COMPANY OVERVIEW 286
TABLE 321 BIO-CAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 286
TABLE 322 BIO-CAT: DEALS 287
TABLE 323 SPECIALTY ENZYMES & PROBIOTICS: COMPANY OVERVIEW 288
TABLE 324 SPECIALTY ENZYMES & PROBIOTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 288
TABLE 325 SPECIALTY ENZYMES & PROBIOTICS: PRODUCT LAUNCHES 289
TABLE 326 CREATIVE ENZYMES: COMPANY OVERVIEW 290
TABLE 327 CREATIVE ENZYMES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 290
TABLE 328 MARKETS ADJACENT TO PET BIOTICS MARKET 306
TABLE 329 PET SUPPLEMENTS MARKET, BY PET TYPE, 2021–2024 (USD MILLION) 307
TABLE 330 PET SUPPLEMENTS MARKET, BY PET TYPE, 2025–2030 (USD MILLION) 307
TABLE 331 PET FOOD INGREDIENTS MARKET, BY FORM, 2019–2022 (USD MILLION) 308
TABLE 332 PET FOOD INGREDIENTS MARKET, BY FORM, 2023–2028 (USD MILLION) 308
LIST OF FIGURES
FIGURE 1 MARKET SCENARIO 34
FIGURE 2 GLOBAL PET BIOTICS MARKET, 2021-2030 35
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PET BIOTICS MARKET
(2020–2025) 35
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PET BIOTICS MARKET 36
FIGURE 5 HIGH-GROWTH SEGMENTS IN PET BIOTICS MARKET, 2025-2030 37
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PET BIOTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 38
FIGURE 7 RISING PET HUMANIZATION AND PREVENTIVE HEALTH FOCUS CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 39
FIGURE 8 DOGS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025 40
FIGURE 9 PROBIOTICS SEGMENT TO DOMINATE MARKET IN 2025 40
FIGURE 10 DOGS SEGMENT TO LEAD MARKET IN 2025 41
FIGURE 11 DRY FOOD SEGMENT TO DOMINATE MARKET IN 2025 41
FIGURE 12 DRY FORM TO DOMINATE MARKET IN 2025 41
FIGURE 13 US TO DOMINATE MARKET 42
FIGURE 14 PET BIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
FIGURE 15 US: EXPENDITURE IN PET INDUSTRY, 2020–2024 (USD BILLION) 50
FIGURE 16 PET BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 56
FIGURE 17 INGREDIENTS MOST FREQUENTLY PERCEIVED TO HAVE HEALTH BENEFITS 59
FIGURE 18 PERCENTAGE INCREASE YEAR OVER YEAR AND COMBINED NUMBER OF
PETS IN US 60
FIGURE 20 PET BIOTICS MARKET: ECOSYSTEM ANALYSIS 64
FIGURE 21 AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION, 2025 (USD) 65
FIGURE 22 AVERAGE SELLING PRICE TREND OF PET BIOTICS, BY REGION,
2021–2024 (USD/TON) 66
FIGURE 23 IMPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS) 67
FIGURE 24 EXPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS) 68
FIGURE 25 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 69
FIGURE 26 INVESTMENT AND FUNDING SCENARIO 70
FIGURE 29 FUTURE APPLICATIONS 83
FIGURE 31 PET BIOTICS MARKET DECISION-MAKING FACTORS 101
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR THREE APPLICATIONS 102
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 103
FIGURE 34 ADOPTION BARRIERS AND INTERNAL CHALLENGES 104
FIGURE 36 PET BIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 140
FIGURE 37 PET BIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION) 148
FIGURE 38 PET BIOTICS MARKET, BY PET, 2025 VS. 2030 (USD MILLION) 153
FIGURE 40 CHINA TO RECORD FASTEST GROWTH DURING FORECAST PERIOD 169
FIGURE 41 NORTH AMERICA: PET BIOTICS MARKET SNAPSHOT 172
FIGURE 42 ASIA PACIFIC: PET BIOTICS MARKET SNAPSHOT 193
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD BILLION) 219
FIGURE 44 MARKET SHARE ANALYSIS, 2024 220
FIGURE 45 COMPANY VALUATION FOR MAJOR PLAYERS IN PET BIOTICS MARKET, 2025 222
FIGURE 46 EV/EBITDA OF MAJOR PLAYERS, 2025 222
FIGURE 47 PET BIOTICS MARKET: BRAND/PRODUCT COMPARISON 223
FIGURE 48 PET BIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 226
FIGURE 49 PET BIOTICS MARKET: COMPANY FOOTPRINT, 2024 227
FIGURE 50 PET BIOTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 232
FIGURE 51 ADM: COMPANY SNAPSHOT 240
FIGURE 52 KERRY GROUP PLC: COMPANY SNAPSHOT 247
FIGURE 53 INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY SNAPSHOT 251
FIGURE 54 DSM-FIRMENICH: COMPANY SNAPSHOT 254
FIGURE 55 CARGILL, INCORPORATED: COMPANY SNAPSHOT 258
FIGURE 56 PROBI: COMPANY SNAPSHOT 263
FIGURE 57 INGREDION: COMPANY SNAPSHOT 266
FIGURE 58 PET BIOTICS MARKET: RESEARCH DESIGN 297
FIGURE 59 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION,
AND REGION 299
FIGURE 60 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 301
FIGURE 61 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 302
FIGURE 62 PET BIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 303
FIGURE 63 DATA TRIANGULATION 304
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11
- 鉄道試験市場規模、シェア、動向、2032年までの世界予測 2025-12-10